Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion

References

• Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–1214.
   PubMed Web of Science ®Google Scholar
• Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787–803.
   PubMed Web of Science ®Google Scholar
• Baloch ZW, LiVolsi VA. Fine-needle aspiration of the thyroid: today and tomorrow. Best Pract Res Clin Endocrinol Metab. 2008;22(6):929–939.
   PubMed Web of Science ®Google Scholar
• DeLellis RA, Lloyd RV, Heinz PU. WHO Classification of Tumours, Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004:73–76.
   Google Scholar
• Yun SK, Kim CH, Kim YS, Byun DW, Suh K, Yoo MH. The efficacy of thyroxine suppression therapy in benign thyroid nodules. Endocrinol Metab. 2000;15(4):532–541.
   Google Scholar
• Cibas ES, Ali SZ. The Bethesda System for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–1165.
   PubMed Web of Science ®Google Scholar
• Petric R, Perhavec A, Gazic B, Besic N. Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland. J Surg Oncol. 2012;105(4):351–356.
   PubMed Web of Science ®Google Scholar
• Besic N, Sesek M, Peric B, Zgajnar J, Hocevar M. Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. Med Sci Monit. 2008;14(9):Cr459–Cr467.
   Google Scholar
• Lee EK, Chung KW, Min HS, et al. Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci. 2012;27(9):1014–1018.
   PubMed Web of Science ®Google Scholar
• Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 1998;8(5):377–383.
   PubMed Web of Science ®Google Scholar
• Lubitz CC, Faquin WC, Yang J, et al. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 2010;20(1):25–31.
   PubMed Web of Science ®Google Scholar
• Patel HH, Goyal N, D. Goldenberg Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer. Ann Med. 2014;46(6):409–416.
   PubMed Web of Science ®Google Scholar
• Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96(11):3390–3397.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Jang HW, Sohn SY, et al. Frequency of RAS mutations and PAX8/PPARγ rearrangement in follicular thyroid tumors in Korea. Endocrinol Metab. 2012;27(1):45–53.
   Google Scholar
• Okamoto T, Kanbe M, Iihara M, et al. Measuring serum thyroglobulin in patients with follicular thyroid nodule: its diagnostic implications. Endocr J. 1997;44(1):187–193.
   PubMed Web of Science ®Google Scholar
• Suh I, Vriens MR, Guerrero MA, et al. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg. 2010;200(1):41–46.
   PubMed Web of Science ®Google Scholar
• Bachelot A, Cailleux AF, Klain M, et al. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid. 2002;12(8):707–711.
   PubMed Web of Science ®Google Scholar
• Wemeau JL, Caron P, Schvartz C, et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab. 2002;87(11):4928–4934.
   PubMed Web of Science ®Google Scholar
• Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab. 2002;87(9):4154–4159.
   PubMed Web of Science ®Google Scholar
• Blum M, Rothschild M. Improved nonoperative diagnosis of the solitary “cold” thyroid nodule. Surgical selection based on risk factors and three months of suppression. JAMA. 1980;243(3):242–245.
   PubMed Web of Science ®Google Scholar
• Hill LD, Beebe HG, Hipp R, Jones HW. Proceedings: Thyroid suppression. Arch Surg. 1974;108(4):403–405.
   PubMedGoogle Scholar
• Morita T, Tamai H, Ohshima A, et al. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules. J Clin Endocrinol Metab. 1989;69(2):227–230.
   PubMed Web of Science ®Google Scholar
• Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med. 2004;351(17):1764–1771.
   PubMed Web of Science ®Google Scholar
• Giovanella L, Suriano S, Ceriani L, Verburg FA. Undetectable thyroglobulin in patients with differentiated thyroid carcinoma and residual radioiodine uptake on a postablation whole-body scan. Clin Nucl Med. 2011;36(2):109–112.
   PubMed Web of Science ®Google Scholar
• Rasmussen LB, Ovesen L, Bulow I, et al. Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, and serum thyroglobulin. Am J Clin Nutr. 2002;76(5):1069–1076.
   PubMed Web of Science ®Google Scholar
• Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148(11):832–845.
   PubMed Web of Science ®Google Scholar
• Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab. 1996;81(12):4278–4289.
   PubMed Web of Science ®Google Scholar